Peter Traber

Plus aucun poste en cours

Profil

Peter G.
Traber currently works at Baylor College of Medicine, as Chief Executive Officer from 2003 to 2008 and Cartesian Therapeutics, Inc., as Head-Research & Development.
Dr. Traber also formerly worked at The University of Pennsylvania Health System, as Chief Executive Officer, Terrasep LLC, as Chairman & Chief Executive Officer, the University of Pennsylvania Medical Center, as Chairman-Internal Medicine Department, Noble International Ltd., as Director, Tanox, Inc., as Director, Caladrius Biosciences, Inc., as Independent Director, Galectin Therapeutics, Inc., as President, Chief Executive & Medical Officer from 2017 to 2018, Selecta Biosciences, Inc., as Chief Medical Officer from 2020 to 2023, GSK Plc, as Chief Medical Officer & SVP-Clinical Development from 2000 to 2003, Morphic Therapeutic, Inc., as Chief Medical Officer, and Alacrita Consulting Ltd., as Partner from 2018 to 2020.
Dr. Traber received his undergraduate degree from the University of Michigan and doctorate degree from The Wayne State University School of Medicine.

Postes actifs de Peter Traber

Sociétés	Poste	Début
Baylor College of Medicine	Directeur/Membre du Conseil	01/01/2008

Anciens postes connus de Peter Traber

Sociétés	Poste	Fin
CARTESIAN THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	13/11/2023
Alacrita Consulting Ltd.	Corporate Officer/Principal	01/08/2020
GALECTIN THERAPEUTICS INC.	Directeur Général	06/07/2018
Tanox, Inc.	Directeur/Membre du Conseil	03/08/2007
GSK PLC	Directeur Technique/Scientifique/R&D	01/01/2003